Bipolar II Depression: Lithium, SSRI, or the Combination
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety and effectiveness of a mood stabilizing medication, an
antidepressant medication, and a combination of both medications to treat symptoms of bipolar
type II depression.
Phase:
Phase 3
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborators:
National Institute of Mental Health (NIMH) Stanford University University of California, Los Angeles